Clinical Trial Update: To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates the efficacy and safety of combining Disitamab Vedotin with Toripalimab as sequential chemotherapy in the neoadjuvant trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Disitamab Vedotin (disitamab vedotin)
• Toripalimab (Toripalimab)

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING